CD36 and hepatocellular carcinoma: Emerging evidence demonstrates that CD36 promotes cancer progression through its role in fatty acid uptake and metabolic reprogramming, especially enhancing tumor cell proliferation, metastasis, and cancer stem-like properties, across several malignancies, including breast, oral, and hepatocellular carcinoma [14,15].